Armin Brott
Tribune News Service
April is National Minority Health Month, making it the perfect time to focus on the often significant disparities in health and well-being that affect racial and ethnic minorities across our country. But itâs important to remember that these inequities exist every single day of the year, not just in April.
What do we mean by âdisparitiesâ and âinequitiesâ? Well, according to the Commonwealth Fund (www.commonwealthfund.org), compared with the general population, members of racial and ethnic minorities are less likely to receive preventive health services and often receive lower-quality care. They also have worse health outcomes for certain conditions.â
By City News Service
Apr 15, 2021
LOS ANGELES (CNS) - The Children s Hospital Los Angeles announced today it received $6.1 million to conduct research into the success of treatments for children s anxiety, which affects one in five youth.
The study, which is funded through the Patient-Centered Outcomes Research Institute, will be the first to measure the success rates of cognitive behavioral therapy and medication, the two common treatments for children with anxiety.
“There hasn t yet been a head-to-head comparison for treatment strategies in real-world settings, said Dr. Bradley Peterson, chief in the division of child psychiatry at CHLA. “We are excited to be able to lay this foundation and finally answer these questions.
Each treatment has shown some success in treating patients, but when children don t go into remission, medical professionals have to decide whether to continue with an intensified version of current treatment or add another treatment.
Clinicians and families also have to consider the cost and the time commitment of therapy when considering it against medications.
“This is a clinical question for every single child who is treated for anxiety across the world,” Peterson said. “Many factors go into the decision of whether to begin with CBT or medication.”
Peterson will collaborate with the U.S. leading experts in youth anxiety to compare the two treatment options success rates. In the study s first phase, researchers will randomly give participants therapy or medication then assess them for 12 weeks.
Source: Getty Images
The CDC’s Advisory Committee on Immunization Practices meets today to review the data that have led, “out of an abundance of caution,” to a recommended pause in the use of J&J’s COVID-19 vaccine in the U.S. The focus is on six cases of what appears to be a very rare but severe type of blood clot, all occurring in women ages 18 to 48, with symptoms developing six to 13 days after vaccination. One woman died and another is hospitalized in critical condition.
Nearly 7 million doses of the single-dose J&J vaccine have been given in this country. The concern is a clot known as cerebral venous sinus thrombosis, occurring in combination with low blood platelets. Traditional treatments for clots, such as heparin, may actually be dangerous in this situation. The CDC and FDA are advising that anyone who has received the J&J vaccine and develops severe headache, abdominal pain, leg pain or shortness of breath within three weeks of being vaccinated should contact
Small Biz Spotlight: AbsoluteJOI, skin care products for women of color bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.